Shanghai Henlius Biotech Inc

Common Name
Shanghai Henlius Biotech
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
3,537
Ticker
2696
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Shanghai Henlius Biotech, Inc. is a global biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of biologic medicines. Established in 2010 and head...

Shanghai Henlius Biotech's GHG Emissions Data Preview

In 2023, Shanghai Henlius Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Shanghai Henlius Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Shanghai Henlius Biotech’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Shanghai Henlius Biotech’s data sources below and access millions more through our Disclosure Search.

a. Shanghai Henlius Biotech's ESG Report 2023
a. Shanghai Henlius Biotech's ESG Report 2023
b. Shanghai Henlius Biotech's ESG Report 2022
b. Shanghai Henlius Biotech's ESG Report 2022

Insights into Shanghai Henlius Biotech's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Shanghai Henlius Biotech amounted to 21,973 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Shanghai Henlius Biotech increased by 3.82%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Shanghai Henlius Biotech's Scope 1 Emissions Over Time

202020212022202302 k4 k6 k8 ktCO2e+13%+4%+7%
  • Total Scope 1
  • Year-over-Year Change

What are Shanghai Henlius Biotech's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Shanghai Henlius Biotech were 6,908.63 metric tons of CO₂ equivalent (tCO₂e). a

Has Shanghai Henlius Biotech reduced its Scope 1 emissions over time?

Since 2020, Shanghai Henlius Biotech's Scope 1 emissions have increased by 24.82%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2022), Shanghai Henlius Biotech's Scope 1 emissions increased by 6.61%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Shanghai Henlius Biotech's Scope 2 emissions?

In 2023, Shanghai Henlius Biotech reported Scope 2 greenhouse gas (GHG) emissions of 15,064.37 tCO₂e without specifying the calculation method. a

Has Shanghai Henlius Biotech reduced its Scope 2 emissions over time?

Since 2020, Shanghai Henlius Biotech's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Shanghai Henlius Biotech 's emissions have plateaued with no significant change in its energy consumption footprint. a b

Compared to the previous year (2022), Shanghai Henlius Biotech's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Shanghai Henlius Biotech 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Shanghai Henlius Biotech use for Scope 2 reporting?

In 2023, Shanghai Henlius Biotech reported its Scope 2 emissions using an unspecified methodology. a

Shanghai Henlius Biotech's Scope 2 Emissions Over Time

202020212022202304.5 k9 k13.5 k18 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Shanghai Henlius Biotech’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Shanghai Henlius Biotech reported Scope 1 greenhouse gas (GHG) emissions of 6,908.63 tCO₂e and total revenues of USD 830 millions. This translates into an emissions intensity of 8.32 tCO₂e per millions USD. a

Shanghai Henlius Biotech's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202002,00020,000Revenues (Millions of USD)AASAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MZhifeiYear: 2023Scope 1: 14,211 tCO2eRevenue: $M 7,446Scope 1 Intensity: 1.91 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MGenor Biopharma HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 3Scope 1 Intensity: 7.17 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$M

How does Shanghai Henlius Biotech's GHG emissions intensity compare to its peers?

In 2023, Shanghai Henlius Biotech reported a Scope 1 emissions intensity of 8.32 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Shanghai Henlius Biotech rank on GHG emissions intensity within its industry?

In 2023, Shanghai Henlius Biotech ranked 11 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Shanghai Henlius Biotech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Shanghai Henlius Biotech's GHG Emissions Dataset?
Sign Up